MeenakshiGHegdeMD

Pediatric Hematology & Oncology • Houston, TX

Physician

Join to view full profile

Dr. Hegde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hegde's full profile

Already have an account?

Office
6701 Fannin St
Houston, TX 77030
Phone+1 832-824-1000

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2006 - 2009
JSS Medical College MysoreClass of 2004

Certifications & Licensure

TX State Medical License 2010 - 2025
IL State Medical License 2006 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors Start of enrollment: 2016 Dec 01
Completed
Phase 1

Publications & Presentations

PubMed

145 citations
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan, Alberto Delaidelli, Sujith K. Joseph, Kevin Bielamowicz, Kristen Fousek
Nature Medicine. 2020-04-27
302 citations
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.
Kevin Bielamowicz, Kristen Fousek, Tiara T. Byrd, Hebatalla Samaha, Malini Mukherjee
Neuro-Oncology. 2018-03-27
563 citations
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra
JAMA Oncology. 2017-08-01

Journal Articles

Retraction Note: A Homing System Targets Therapeutic T Cells to Brain Cancer
Nabil Ahmed, Fong W Lam, Meenakshi Hegde, Jordan S Orange, Thomas Shum, Rakesh K Jain, Nature

Press Mentions

Baylor College of Medicine Receives More Than $17 Million from CPRITAugust 21st, 2024
The Faris Foundation Grant Funds Research for Advanced Sarcoma Clinical TrialDecember 4th, 2020
$HER2 CAR T Therapy Dramatically Improves Child’s Refractory Cancer$
HER2 CAR T Therapy Dramatically Improves Child’s Refractory CancerJuly 16th, 2020
Join now to see all